Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Mayo Clinic research in mice finds new role for Interleukin-6

10.01.2003


A Mayo Clinic investigation of Interleukin-6, a hormone inside cells often considered a "bad actor" of the immune system because of its association with inflammation injuries and malignant diseases, shows that it also plays a therapeutic role in mice: it protects brain cells.



Interleukin-6 -- called IL-6 for short by researchers -- may, in fact, be a "white knight" for mouse brain cells, or neurons, as brain cells also are called. These results, while early, may be promising for humans as well. The Mayo Clinic investigation is described in the Jan. 15 Journal of Neuroscience.

Clinical Importance


Every part of the brain is connected by neurons. Yet both the aging process and many diseases are a steady assault on neurons. Says Moses Rodriguez, M.D., principal investigator of the Mayo Clinic study, "One of the biggest challenges we face as a society is the eventual loss and degeneration of neurons from many causes, including many diseases -- from Alzheimer’s disease to multiple sclerosis to Parkinson’s disease -- and other sorts of injury. As our population gets older, this becomes an even bigger issue. So identifying any factor that protects neurons or promotes their survival is an important step toward improving health as we age."

This protective response holds considerable therapeutic significance since scientists already know how to make IL-6 in the laboratory. It may, therefore, be an appealing candidate for researchers to refine into an easily administered drug -- a "brain booster" pill that conserves mental functioning, for example.

If these early results hold up in further studies, IL-6 -- or other similar pharmaceutical compounds -- could potentially serve as a new treatment for a range of conditions that destroy neurons, from Alzheimer’s disease to multiple sclerosis. Says Dr. Rodriguez, "Every disease that is a degenerative disease of the nervous system could potentially be amenable to some kind of treatment with a growth factor like IL-6 because its goal is to keep neurons alive."

The Experiment

To function in a cell, IL-6 has to bind in a specific place -- called a "receptor site" -- in a specific way. Dr. Rodriguez and colleagues were intrigued that IL-6 uses the same receptor site used by compounds whose job is to promote neuronal survival. "To me, that was pretty wild," Dr. Rodriguez says. "So I hypothesized that maybe this IL-6 is also playing a role in protecting neurons."

Testing this idea required extensive genetic work to produce different mouse groups that varied in their ability to produce IL-6. All were infected with a virus that causes a degenerative nerve disease. Animals with the IL-6 gene got mildly sick, but did not die. Mice lacking the IL-6 gene got severely sick and started dying. Why?

To find a cause of death, the Mayo Clinic team analyzed the animals’ tissues. Their findings: neurons in the spinal cords of mice lacking IL-6 were degenerating dramatically. This evidence supported their hypothesis of a neuron-protection role for IL-6. It also led them to their next question: Where is IL-6 made?

An analysis of the brains of healthy mice possessing the IL-6 gene surprised them. "You look for IL-6 in the brain of a normal, healthy animal, and there is no IL-6 in a normal healthy animal!" Dr. Rodriguez says. "So then we infected the animals with the virus. Now when we looked for IL-6, guess what? It was everywhere."

Specifically, IL-6 was found in astrocytes. Astrocytes are the supporting structures on the outside of neurons that help them connect to transmit nerve signals. Says Dr. Rodriguez, "As soon as you put this virus in, all those astrocytes -- like a lightbulb -- go on to make IL-6." Their data show that of infected mice possessing IL-6, only two of 23 (~9 percent) died. By comparison, 17 of 29 mice (~60 percent) lacking IL-6 died after virus infection.

Intriguing Implications … Scientific Basis for Mind-Body Connection in Health

Since its discovery several decades ago, IL-6 has been called a "cytokine." A cytokine is a substance secreted by the immune system. It plays a key role in regulating cells that do the work of the immune system, which is to defend the body from infection and injury.

While IL-6 is unquestionably a cytokine and as such, a proper "citizen" of the immune system, this new Mayo Clinic finding suggests a more complex identity of IL-6. Given its production in astrocytes, it seems IL-6 holds "dual citizenship" by also working in the realm of the brain to protect against neuronal injury. It is this intersection of mind-body systems that Dr. Rodriguez finds most intriguing.

"There is so much that we don’t know about immune-neural interactions that are really important," he says. "For example, I’m a physician and I see a lot of patients. And I know that patients who take care of their bodies are helping their immune systems. I could believe that after we do the right kinds of things for our bodies -- exercise, eat right, rest -- we feel better and we think better because we are activating the right immune systems and because immune factors are acting in our brains. So it doesn’t surprise me that we are now finding that there may be immune factors that are actually very beneficial for neurons. We just didn’t know what they were before."

He notes that this intersection of the immune and neuronal systems of the brain fits with many traditional and ancient healing practices that accept a mind-body connection as a foundation of health. "Maybe there’s a whole scientific basis for it all, and this finding is part of it," Dr. Rodriguez says.

The Next Step

The Mayo Clinic researchers will continue to investigate the receptors for IL-6 in animal models and do other experimental work that could lead to clinical trials in humans. But Dr. Rodriguez cautions that this step is many years away. Much basic science remains to be done.


###
Lisa Copeland
507-284-5005 (days)
507-284-2511(evenings)
email: newsbureau@mayo.edu

Lisa Copeland | EurekAlert!
Further information:
http://www.mayo.edu/

More articles from Life Sciences:

nachricht Researchers identify potentially druggable mutant p53 proteins that promote cancer growth
09.12.2016 | Cold Spring Harbor Laboratory

nachricht Plant-based substance boosts eyelash growth
09.12.2016 | Fraunhofer-Institut für Angewandte Polymerforschung IAP

All articles from Life Sciences >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Electron highway inside crystal

Physicists of the University of Würzburg have made an astonishing discovery in a specific type of topological insulators. The effect is due to the structure of the materials used. The researchers have now published their work in the journal Science.

Topological insulators are currently the hot topic in physics according to the newspaper Neue Zürcher Zeitung. Only a few weeks ago, their importance was...

Im Focus: Significantly more productivity in USP lasers

In recent years, lasers with ultrashort pulses (USP) down to the femtosecond range have become established on an industrial scale. They could advance some applications with the much-lauded “cold ablation” – if that meant they would then achieve more throughput. A new generation of process engineering that will address this issue in particular will be discussed at the “4th UKP Workshop – Ultrafast Laser Technology” in April 2017.

Even back in the 1990s, scientists were comparing materials processing with nanosecond, picosecond and femtosesecond pulses. The result was surprising:...

Im Focus: Shape matters when light meets atom

Mapping the interaction of a single atom with a single photon may inform design of quantum devices

Have you ever wondered how you see the world? Vision is about photons of light, which are packets of energy, interacting with the atoms or molecules in what...

Im Focus: Novel silicon etching technique crafts 3-D gradient refractive index micro-optics

A multi-institutional research collaboration has created a novel approach for fabricating three-dimensional micro-optics through the shape-defined formation of porous silicon (PSi), with broad impacts in integrated optoelectronics, imaging, and photovoltaics.

Working with colleagues at Stanford and The Dow Chemical Company, researchers at the University of Illinois at Urbana-Champaign fabricated 3-D birefringent...

Im Focus: Quantum Particles Form Droplets

In experiments with magnetic atoms conducted at extremely low temperatures, scientists have demonstrated a unique phase of matter: The atoms form a new type of quantum liquid or quantum droplet state. These so called quantum droplets may preserve their form in absence of external confinement because of quantum effects. The joint team of experimental physicists from Innsbruck and theoretical physicists from Hannover report on their findings in the journal Physical Review X.

“Our Quantum droplets are in the gas phase but they still drop like a rock,” explains experimental physicist Francesca Ferlaino when talking about the...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

ICTM Conference 2017: Production technology for turbomachine manufacturing of the future

16.11.2016 | Event News

Innovation Day Laser Technology – Laser Additive Manufacturing

01.11.2016 | Event News

#IC2S2: When Social Science meets Computer Science - GESIS will host the IC2S2 conference 2017

14.10.2016 | Event News

 
Latest News

Researchers identify potentially druggable mutant p53 proteins that promote cancer growth

09.12.2016 | Life Sciences

Scientists produce a new roadmap for guiding development & conservation in the Amazon

09.12.2016 | Ecology, The Environment and Conservation

Satellites, airport visibility readings shed light on troops' exposure to air pollution

09.12.2016 | Health and Medicine

VideoLinks
B2B-VideoLinks
More VideoLinks >>>